Increased vaccine tolerability and protection via NF-κB modulation

Abstract

Inflammation can be decoupled from the antigen-presenting actions of adjuvants using an immune potentiator that modulates NF-κB.

Document Details

Document Type
Pub Defense Publication
Publication Date
Sep 11, 2020
Source ID
10.1126/sciadv.aaz8700

Entities

People

  • Aaron P Esser-Kahn
  • B. G. Mcgonnigal
  • B. J. Cassaidy
  • Brittany Moser
  • David Boltz
  • K. M. Barker
  • Matthew Rosenberger
  • Rachel C Steinhardt
  • Stan Yoo
  • Y. Escalante-buendia

Organizations

  • Defense Threat Reduction Agency
  • Illinois Institute of Technology
  • National Institutes of Health
  • National Science Foundation
  • University of California
  • University of Chicago

Tags

Technology Areas

  • Biotechnology
  • Biotechnology - Cancer Biotech